Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 499 participants.

Also called NCT01827046

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 499 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01827046
Other papers using this trial's data
  • Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trial Journal of neurology, neurosurgery, and psychiatry, 2024-09-17 DOI, PubMed 38670789, PMC12054398 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial Lancet (London, England), 2019-03-09 DOI, PubMed 30739747, PMC6894906 PubMed links an erratum for this paper. Erratum: PMID 31007203 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Intracerebral haemorrhage laterality and associations with mood and pain: a MISTIE III substudy Stroke and vascular neurology, 2025-12-23 DOI, PubMed 40250866, PMC12772961 In the PMC Open Access subset under CC BY-NC.
  • Mechanistic Evaluation of Diffusion Weighted Hyperintense Lesions After Large Spontaneous Intracerebral Hemorrhage: A Subgroup Analysis of MISTIE III Neurocritical care, 2024-06 DOI, PubMed 38040993
  • Minimally Invasive Surgery With Thrombolysis for Intracerebral Hemorrhage Evacuation: Bayesian Reanalysis of a Randomized Controlled Trial Neurology, 2023-10-17 DOI, PubMed 37684058, PMC10585679 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Canada, China, Germany, Hungary, Israel, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01827046. Randomized; single masking; primary purpose treatment. Start 2013-12-30 (actual); primary completion 2018-09 (actual). Results posted on 2019-09-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
Acronym
MISTIE-III
Condition
Intracerebral Hemorrhage
Intervention (Drug)
rt-PA
Lead sponsor
Johns Hopkins University (class: other)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)
Collaborator
Genentech, Inc. (class: industry)
Collaborator
Emissary International LLC (class: industry)

Record details

Record id
cardio:ct-nct01827046
Content hash
267e804b2d594acfc4bdbb2653b2d7bbeb55fe6aacbd015ebf9bde5ad7a6182a